Adrienn Bı́ró

597 total citations
19 papers, 497 citations indexed

About

Adrienn Bı́ró is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Adrienn Bı́ró has authored 19 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Rheumatology. Recurrent topics in Adrienn Bı́ró's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Complement system in diseases (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Adrienn Bı́ró is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Complement system in diseases (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Adrienn Bı́ró collaborates with scholars based in Hungary, France and Austria. Adrienn Bı́ró's co-authors include George Füst, Zoltán Prohászka, Gérard J. Arlaud, László Cervenak, Nicole M. Thielens, Lilian Varga, Wai Li Ling, Judit Kocsis, Diána Papp and Zita Rovó and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Adrienn Bı́ró

19 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrienn Bı́ró Hungary 12 250 168 68 53 45 19 497
Daniel Cioca Romania 12 252 1.0× 277 1.6× 97 1.4× 29 0.5× 42 0.9× 24 656
Margaret Neighbors United States 11 556 2.2× 146 0.9× 64 0.9× 31 0.6× 45 1.0× 23 871
Julie Mussard France 10 504 2.0× 194 1.2× 54 0.8× 65 1.2× 32 0.7× 13 680
Anna Wardowska Poland 16 235 0.9× 196 1.2× 70 1.0× 52 1.0× 25 0.6× 41 625
Uriel Trahtemberg Israel 14 465 1.9× 187 1.1× 43 0.6× 79 1.5× 46 1.0× 24 688
Donna Morton United States 8 358 1.4× 126 0.8× 95 1.4× 41 0.8× 29 0.6× 11 693
Keith W. Wegmann United States 17 669 2.7× 191 1.1× 118 1.7× 45 0.8× 31 0.7× 29 1.2k
Lucy Bird United States 10 340 1.4× 199 1.2× 62 0.9× 140 2.6× 43 1.0× 185 711
Katharina‐Susanne Spanaus Switzerland 10 410 1.6× 206 1.2× 115 1.7× 46 0.9× 29 0.6× 12 840
D. Bilsland United Kingdom 14 357 1.4× 82 0.5× 60 0.9× 89 1.7× 66 1.5× 30 843

Countries citing papers authored by Adrienn Bı́ró

Since Specialization
Citations

This map shows the geographic impact of Adrienn Bı́ró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienn Bı́ró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienn Bı́ró more than expected).

Fields of papers citing papers by Adrienn Bı́ró

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienn Bı́ró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienn Bı́ró. The network helps show where Adrienn Bı́ró may publish in the future.

Co-authorship network of co-authors of Adrienn Bı́ró

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienn Bı́ró. A scholar is included among the top collaborators of Adrienn Bı́ró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienn Bı́ró. Adrienn Bı́ró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ling, Wai Li, Adrienn Bı́ró, Isabelle Bally, et al.. (2011). Proteins of the Innate Immune System Crystallize on Carbon Nanotubes but Are Not Activated. ACS Nano. 5(2). 730–737. 46 indexed citations
2.
Arlaud, Gérard J., Adrienn Bı́ró, & Wai Li Ling. (2011). Enzymatically Modified Low-Density Lipoprotein Is Recognized by C1q and Activates the Classical Complement Pathway. SHILAP Revista de lepidopterología. 2011. 1–5. 8 indexed citations
3.
Várbı́ró, Szabolcs, Adrienn Bı́ró, Judit Cervenak, et al.. (2010). Human anti-60 kD heat shock protein autoantibodies are characterized by basic features of natural autoantibodies. Acta Physiologica Hungarica. 97(1). 1–10. 13 indexed citations
4.
Bı́ró, Adrienn, Wai Li Ling, & Gérard J. Arlaud. (2010). Complement Protein C1q Recognizes Enzymatically Modified Low-Density Lipoprotein through Unesterified Fatty Acids Generated by Cholesterol Esterase. Biochemistry. 49(10). 2167–2176. 16 indexed citations
5.
Beck, Zoltán, Andrea Balogh, László Cervenak, et al.. (2009). New cholesterol-specific antibodies remodel HIV-1 target cells’ surface and inhibit their in vitro virus production. Journal of Lipid Research. 51(2). 286–296. 11 indexed citations
6.
Jakab, László, Judit Laki, T Pozsonyi, et al.. (2007). Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clinical Immunology. 125(3). 230–236. 31 indexed citations
7.
Kocsis, Judit, Adrienn Bı́ró, Zsuzsa Pocsai, et al.. (2007). The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. International Journal of Cancer. 121(8). 1744–1748. 36 indexed citations
8.
Bı́ró, Adrienn, Zita Rovó, Diána Papp, et al.. (2007). Studies on the interactions between C‐reactive protein and complement proteins. Immunology. 121(1). 40–50. 102 indexed citations
9.
Varga, Lilian, Adrienn Bı́ró, Gábor Széplaki, et al.. (2007). Anti‐cholesterol antibody levels in hereditary angioedema. Journal of Cellular and Molecular Medicine. 11(6). 1377–1383. 4 indexed citations
10.
Bı́ró, Adrienn, Nicole M. Thielens, László Cervenak, et al.. (2006). Modified low density lipoproteins differentially bind and activate the C1 complex of complement. Molecular Immunology. 44(6). 1169–1177. 56 indexed citations
11.
Bı́ró, Adrienn, László Cervenak, Andrea Balogh, et al.. (2006). Novel anti-cholesterol monoclonal immunoglobulin G antibodies as probes and potential modulators of membrane raft-dependent immune functions. Journal of Lipid Research. 48(1). 19–29. 28 indexed citations
13.
Bı́ró, Adrienn, Edit Dósa, Anna Horváth, et al.. (2005). Dramatic changes in the serum levels of anti-cholesterol antibodies after eversion endarterectomy in patients with severe carotid atherosclerosis. Immunology Letters. 99(1). 51–56. 4 indexed citations
14.
Füst, George, Zoltán Beck, Dénes Bánhegyi, et al.. (2004). Antibodies against heat shock proteins and cholesterol in HIV infection. Molecular Immunology. 42(1). 79–85. 22 indexed citations
15.
Quintana, Francisco J., Edit I. Buzás, Zoltán Prohászka, et al.. (2004). Knock-out of the histidine decarboxylase gene modifies the repertoire of natural autoantibodies. Journal of Autoimmunity. 22(4). 297–305. 17 indexed citations
16.
Horváth, Anna & Adrienn Bı́ró. (2003). Anti-cholesterol antibodies in human sera. Autoimmunity Reviews. 2(5). 272–277. 8 indexed citations
17.
Bı́ró, Adrienn, Anna Horváth, Lilian Varga, et al.. (2003). Serum Anti-cholesterol Antibodies in Chronic Hepatitis-C Patients During IFN-α-2b Treatment. Immunobiology. 207(3). 161–168. 9 indexed citations
18.
Kocsis, Judit, Zoltán Prohászka, Adrienn Bı́ró, George Füst, & Dénes Bánhegyi. (2003). Elevated levels of antibodies against 70 kDa heat shock proteins in the sera of patients with HIV infection. Journal of Medical Virology. 71(4). 480–482. 20 indexed citations
19.
Füst, George, Marek Smieja, Matthew McQueen, et al.. (2002). Relationship of Anti-60 kDa Heat Shock Protein and Anti-Cholesterol Antibodies to Cardiovascular Events. Circulation. 106(22). 2775–2780. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026